<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056662</url>
  </required_header>
  <id_info>
    <org_study_id>3237</org_study_id>
    <nct_id>NCT05056662</nct_id>
  </id_info>
  <brief_title>Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions</brief_title>
  <acronym>PROPHET-FFR</acronym>
  <official_title>Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions: an FFR-based Single Center Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PROPHET-FFR is a single center ambispective registry aiming to explore the impact of&#xD;
      post-revascularization functional assessment on later outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROPHET-FFR is a ambispective observational study enrolling patients that need invasive&#xD;
      functional evaluation in the diagnostic workup of coronary artery disease.&#xD;
&#xD;
      Clinical outcomes of patients that undergo functional assessment after PCI will be compared&#xD;
      both to patients undergoing PCI without further evaluations and both to patients that will be&#xD;
      deferred due to to negative functional evaluation.&#xD;
&#xD;
      Since the observational nature of the study the decision to perform post-PCI physiological&#xD;
      assessment will be left to operator's discretion.&#xD;
&#xD;
      In case of post-PCI functional evaluation results that will be deemed as unsatisfactory by&#xD;
      the operator further actions can be taken in order to optimize procedural result. The&#xD;
      decision on this opportunity as well as the choice of the strategy to adopt are left to&#xD;
      operator's discretion.&#xD;
&#xD;
      The primary endpoint of the study is the rate of MACE defined as the composite of spontaneous&#xD;
      MI, target vessel failure, cardiac deaths at 24 months. Follow up will be performed by&#xD;
      telephone contact and medical records screening at 12, 24 and 36 months.&#xD;
&#xD;
      Moreover data about in-hospital events will be collected including the release of myocardial&#xD;
      damage markers, change in Creatinine, and lenght of hospital stay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 4, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Rate of composite of Major Adverse Cardiovascular Events (MACE) [ Cardiac Death/Myocardial Infarction/Target Vessel Failure (TVF)]</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of any component of MACE (Cardiac Death/Myocardial Infarction/Target Vessel Failure (TVF)]</measure>
    <time_frame>1 year, 3 years, 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause Death</measure>
    <time_frame>1 year, 3 years, 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of recurrent or persistent angina</measure>
    <time_frame>1 year, 3 years, 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of change in angina intensity assessed by shortened Seattle Angina Questionnaire-7</measure>
    <time_frame>1 year, 3 years, 5 years</time_frame>
    <description>A score ranging from 0 to 100, with the higher values associated with less severe symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiac hospitalizations</measure>
    <time_frame>1 year, 3 years, 5 years</time_frame>
    <description>Any hospitalization for cardiac causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>absolute and relative change in functional indexes measured before and after any step of the study procedure</measure>
    <time_frame>intraprocedural</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-procedural troponin level</measure>
    <time_frame>24 hours and 48 hours</time_frame>
    <description>ng/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-procedural creatinine level</measure>
    <time_frame>24 hours and 48 hours</time_frame>
    <description>mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedural cost</measure>
    <time_frame>intraprocedural</time_frame>
    <description>Euro</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluoroscopy time</measure>
    <time_frame>intraprocedural</time_frame>
    <description>minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>contrast dose</measure>
    <time_frame>intraprocedural</time_frame>
    <description>mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of stents implanted and balloon used for optimization</measure>
    <time_frame>intraprocedural</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <condition>Angina, Stable</condition>
  <condition>Non ST Elevation Myocardial Infarction</condition>
  <condition>ST Elevation Myocardial Infarction</condition>
  <condition>Unstable Angina</condition>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients with negative invasive functional evaluation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients with positive invasive functional evaluation undergoing PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Patients with positive invasive functional evaluation undergoing PCI and subsequent retest of functional indexes</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Invasive functional evaluation with either Pd/Pa, FFR, iFR or contrast FFR</intervention_name>
    <description>Enrolled patients will undergo invasive functional evaluation of coronary stenosis followed by percutaneous revascularization if appropriate. Patients in Group 3 will have target lesion re-assessed using either PdPa, FFR, iFR or contrast FFR.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring invasive functional evaluation of epicardial stenosis to guide&#xD;
        revascularization.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  requiring coronary angiography to assess coronary artery disease;&#xD;
&#xD;
          -  having at least one angiographically intermediate coronary stenosis (eg. 40%-80%) on&#xD;
             any vessel requiring invasive functional assessment using FFR (and/or any other&#xD;
             surrogate index)&#xD;
&#xD;
          -  being able and legally entitled to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of severe poorly uncontrolled pulmonary disease&#xD;
&#xD;
          -  hemodynamic instability during the diagnostic or therapeutic procedures;&#xD;
&#xD;
          -  known adenosine intolerance&#xD;
&#xD;
          -  need of mechanical circulatory or ventilatory support;&#xD;
&#xD;
          -  stage IV chronic kidney disease.&#xD;
&#xD;
          -  life expectancy &lt;1 year&#xD;
&#xD;
          -  patients gaining indication to surgical revascularization;&#xD;
&#xD;
          -  major procedural complications during percutaneous revascularization (cardiac arrest&#xD;
             needing cardiopulmonary resuscitation, major bleeding , large iatrogenic coronary&#xD;
             dissection, coronary embolization in a main vessel, suspected stroke) making post-PCI&#xD;
             functional evaluation unsafe or impossible.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Maria Leone, PI</last_name>
    <phone>0630155950</phone>
    <email>antoniomarialeone@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANTONIO MARIA LEONE, PI</last_name>
      <email>antoniomarialeone@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 22, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</investigator_affiliation>
    <investigator_full_name>Antonio Maria Leone, MD</investigator_full_name>
    <investigator_title>Principal Investigator, Head of Chronic Coronary Syndromes Department at Fondazione Policlinico A. Gemelli</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

